{"changes":[],"country":"US","description":"Cardurion Pharmaceuticals develops cardiovascular treatments centered on PDE9 inhibition for heart failure and CaMKII inhibition for arrhythmias and rare heart conditions. It targets patients with chronic heart failure and rare genetic diseases like CPVT who lack adequate therapies today. The company is the first to advance a CaMKII inhibitor through clinical studies, opening multiple cardiac indications around the mechanism.","domain":"cardurion.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech|cardiovascular|therapeutics","investors":[],"lat":42.504817,"lng":-71.195611,"location":"Burlington MA","name":"Cardurion Pharmaceuticals","rounds":[{"amountQuarantined":false,"amountUsd":260000000,"currency":"USD","date":"2024-07-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"cardurion-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"cardurion.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://cardurion.com"},{"fact":"description","publisher":"cardurion.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://cardurion.com"}],"stage":"series-b+","techStack":["Cloudflare","WordPress","Yoast SEO 27.4","Google Tag Manager","Gravity Forms 2.10.2","jQuery Migrate 3.4.1","imagesLoaded 5.0.0","Elementor 4.0.3","Essential Addons for Elementor","Cloudflare Bot Management","ZURB Foundation","WP Engine"],"totalRaisedUsd":260000000,"updatedAt":"2026-05-05"}